Jomed Stakes Out the US
By all accounts, the one piece missing from the puzzle for Jomed NV, the small European supplier making waves in the highly competitive field of interventional cardiology, has been a US presence. Thus, most industry observers saw the value in Jomed's merger with Endosonics as providing it with a US sales and marketing infrastructure.
You may also be interested in...
The contribution that Europeans, particularly European physicians and surgeons, have made to the cardiology and cardiovascular industries has been enormous. Why then have Europeans lagged far behind their US counterparts in one important area--company creation? If there is a candidate to play in the cardiovascular device industry's elite ranks, it's Sorin Group, a company with a diverse holding in a wide range of cardiology and cardiovascular device segments.
Former Jomed CEO Tor Peters is back, trying to build another major device company, this time in interventional neurology and modeled after the strategy he used at Jomed.
For Volcano Therapeutics, the addition of Jomed's IVUS business is both an addition to and diversification beyond its current play in thermography as a diagnostic tool to detect vulnerable plaque.